Jaguar Gene Therapy is spinning out a new company to handle the specialized work of manufacturing cell and gene therapies, launching Wednesday a wholly owned subsidiary called Advanced Medicine Partners.
The spinout, which is backed by investors Deerfield Management, Arch Venture Partners and others, will provide manufacturing support to Jaguar as well as Deerfield-backed companies. It has also begun work for “several” biotechnology and pharmaceutical clients, the company said in a statement.
